American Healthcare REIT (AHR) Citi’s Miami Global Property CEO Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Citi’s Miami Global Property CEO Conference 2026 summary
4 Mar, 2026Market fundamentals and growth outlook
Senior housing and long-term care segments show strong supply-demand fundamentals, supporting robust organic earnings growth and favorable cost of capital, enabling both internal and external expansion.
Guidance indicates nearly 18% NFFO per share growth at the midpoint, with a safe balance sheet at 3.4x net debt to EBITDA.
Sector benefits from demographic tailwinds, with 10,000 people turning 80 daily and limited new construction (less than 1% of stock under construction), supporting sustained growth.
Occupancy in RIDEA segments grew by 270–280 basis points last year, with continued demand expected as baby boomers age.
Revenue mix and operational strategy
Trilogy segment leverages a mix of private pay, Medicare Advantage, and Medicaid, optimizing revenue by partnering with high-reimbursement plans and focusing on quality ratings.
Medicare Advantage business achieved over 8.5% rate growth by selectively partnering with top plans; trend expected to continue as occupancy rises.
Revenue growth is further driven by shifting resident mix toward higher-reimbursement sources, with a 2% decrease in Medicaid days and more post-acute admissions.
Unique integrated care model
Trilogy operates integrated campuses combining skilled nursing, assisted living, memory care, and independent living, creating referral synergies and operational efficiencies.
Purpose-built facilities average 10–11 years old, offering a modern, continuum-of-care environment that enhances resident experience and competitive positioning.
Management contract with Trilogy is heavily incentive-based, aligned with EBITDA growth, and paid in stock, fostering strong operator alignment and value creation.
Latest events from American Healthcare REIT
- Double-digit NOI growth and strong occupancy highlight robust performance and future growth potential.AHR
Investor presentation2 Mar 2026 - Double-digit NOI and NFFO growth in 2025, with strong 2026 guidance and major acquisitions.AHR
Q4 202527 Feb 2026 - Strong Q2 results, raised 2024 guidance, and improved leverage driven by SHOP and ISHC growth.AHR
Q2 20242 Feb 2026 - Strong organic growth and disciplined capital allocation drive value, led by the Trilogy platform.AHR
Nareit REIT Week: 2024 Investor Conference31 Jan 2026 - Q3 2024 saw strong NOI and revenue growth, raised guidance, and improved leverage after key acquisitions.AHR
Q3 202414 Jan 2026 - Strong multi-year growth driven by managed care, Trilogy synergies, and portfolio optimization.AHR
Citi’s 30th Annual Global Property CEO Conference 202523 Dec 2025 - Double-digit NOI and FFO growth in 2024, with strong 2025 guidance and improved leverage.AHR
Q4 202417 Dec 2025 - Annual meeting to vote on directors, auditor, executive pay, and new equity plan amid strong 2024 results.AHR
Proxy Filing2 Dec 2025 - Annual meeting covers director elections, auditor, compensation, and new stock purchase plan.AHR
Proxy Filing2 Dec 2025